These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12458328)

  • 41. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in dipeptidyl peptidase IV activity in the serum of patients with uterine cervix carcinoma before and after therapy].
    Sedo A; Liberoff L
    Cesk Gynekol; 1986 Dec; 51(10):772-6. PubMed ID: 2879642
    [No Abstract]   [Full Text] [Related]  

  • 43. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
    Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
    PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevation of plasma soluble CD26 levels during pregnancy.
    Zhao S; Song M; Fan Y; Chang Q; Yi W; Li P; Hu C
    J Obstet Gynaecol Res; 2012 Jan; 38(1):272-9. PubMed ID: 21917073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
    Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
    J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies.
    Matić IZ; Đorđević M; Đorđić M; Grozdanić N; Damjanović A; Kolundžija B; Vidović A; Bila J; Ristić S; Mihaljević B; Tomin D; Milanović N; Ristić D; Purić M; Gavrilović D; Cordero OJ; Juranić ZD
    Leuk Lymphoma; 2013 Dec; 54(12):2701-6. PubMed ID: 23469960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD26/Dipeptidyl Peptidase IV and Its Multiple Biological Functions.
    Pan K; Ohnuma K; Morimoto C; Dang NH
    Cureus; 2021 Feb; 13(2):e13495. PubMed ID: 33777580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic utility of serum dipeptidyl peptidase (DPP- IV) /CD26 as a serum marker in Egyptian patients with colorectal cancer.
    Elzefzafy WM; Abd Elrahman S; Mohmmed ZA; Atef N
    J Immunoassay Immunochem; 2020 Jul; 41(4):729-744. PubMed ID: 32223519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells.
    Lefort EC; Blay J
    Clin Exp Metastasis; 2011 Apr; 28(4):337-49. PubMed ID: 21298326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dipeptidyl peptidase IV (DDP IV) in NASH patients.
    Balaban YH; Korkusuz P; Simsek H; Gokcan H; Gedikoglu G; Pinar A; Hascelik G; Asan E; Hamaloglu E; Tatar G
    Ann Hepatol; 2007; 6(4):242-50. PubMed ID: 18007554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer.
    Ayude D; Páez de la Cadena M; Cordero OJ; Nogueira M; Ayude J; Fernández-Briera A; Rodríguez-Berrocal FJ
    Dis Markers; 2003-2004; 19(6):267-72. PubMed ID: 15258327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum dipeptidyl peptidase IV activities in Czernobyl zone inhabitants exposed to the power-station catastrophe.
    Sedo A; Malik R; Votruba M; Hanic T; Hanic O
    Eur J Clin Chem Clin Biochem; 1996 May; 34(5):447-8. PubMed ID: 8790982
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of narrowband ultraviolet B therapy on serum levels of CD26/dipeptidyl-peptidase IV and truncated forms of substance P in psoriasis patients with pruritus.
    Kongthong S; Phumyen A; Meephansan J
    Clin Cosmet Investig Dermatol; 2019; 12():597-604. PubMed ID: 31692558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo.
    Matić IZ; Ðorđić M; Grozdanić N; Damjanović A; Kolundžija B; Erić-Nikolić A; Džodić R; Šašić M; Nikolić S; Dobrosavljević D; Rašković S; Andrejević S; Gavrilović D; Cordero OJ; Juranić ZD
    BMC Immunol; 2012 Aug; 13():48. PubMed ID: 22908963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential of soluble CD26 as a serum marker for colorectal cancer detection.
    Cordero OJ; Imbernon M; Chiara LD; Martinez-Zorzano VS; Ayude D; de la Cadena MP; Rodriguez-Berrocal FJ
    World J Clin Oncol; 2011 Jun; 2(6):245-61. PubMed ID: 21773075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD26: a key molecule in immune regulation and autoimmune diseases.
    Hosono O; Ohnuma K; Dang NH; Morimoto C
    Mod Rheumatol; 2003 Sep; 13(3):199-204. PubMed ID: 24387205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters.
    Durinx C; Neels H; Van der Auwera JC; Naelaerts K; Scharpe S; De Meester I
    Clin Chem Lab Med; 2001 Feb; 39(2):155-9. PubMed ID: 11341750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of CD26+ Cancer Stem Cells with Metastatic Properties in Colorectal Carcinogenesis.
    Cheung AH; Iyer DN; Lam CS; Ng L; Wong SKM; Lee HS; Wan T; Man J; Chow AKM; Poon RT; Pang R; Law WL
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters.
    Lu Z; Qi L; Bo XJ; Liu GD; Wang JM; Li G
    J Res Med Sci; 2013 Aug; 18(8):647-52. PubMed ID: 24379839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Letter to the editor concerning 'Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies'.
    Hassan WA; Bjerre M; Hjortebjerg R; Magnusson NE; Ramshanker N; Frystyk J
    Ann Oncol; 2015 Jan; 26(1):252-253. PubMed ID: 25355718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.